Facebook
Twitter
LinkedIn
ForwardPerioperative Medication Management
Steven L. Cohn, MD, MACP, SFHM, FRCP
If you are a Program Director and would like to grant access to your trainees, please reach out to education@hospitalmedicine.org for an academic access code.
Summary
Although general internists and subspecialists are familiar with prescribing and managing medications in typical outpatient and inpatient venues, the perioperative period represents a challenging and often unfamiliar setting. This module will outline the principles, available evidence, and expert opinion to be considered when making perioperative management recommendations for some of the most commonly prescribed medications.
Learning Objectives
After completing the module, the participant should be able to:
- Analyze the risks and benefits underlying perioperative management of antiplatelet and anticoagulant medications.
- Recognize the importance of continuing most cardiovascular medications perioperatively.
- Recognize the importance of continuing most pulmonary medications perioperatively.
- Assess when stress dose steroids are indicated and manage other endocrine medications in the perioperative period.
- List the theoretical risks of continuing neuropsychiatric medications and decide whether or not to discontinue them.
- Identify and discontinue herbal medications that may adversely impact perioperative outcomes.
- Analyze the risks and benefits underlying perioperative management of antirheumatic medications.
Instructions
The following is an interactive educational module designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of several sections: a pre-test, a study program, a post-test and a CME evaluation. All sections must be completed to receive CME credit.
Additional Information
| Attachment | Size |
|---|---|
 Perioperative Medication Management - References | 185.63 KB |
Author
Steven L. Cohn, MD, MACP, SFHM, FRCP
Dr. Cohn reports having minor stock holdings in Abbvie, Bristol Myers Squibb, GlaxoSmithKline, Merck & Co, Inc, Moderna, Opko, and Pfizer Inc; and Speaker Honoria for Janssen.
Editors
Leonard Feldman, MD, FACP, SFHM
Kurt Pfeifer, MD, FACP, SFHM
Disclosures
The faculty and planners of these activities have no relevant relationships to disclose unless denoted above. All relevant relationships were mitigated prior to the start of this activity.
Conflict of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.
Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.
Accreditation Statement
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Statement Designation
The Society of Hospital Medicine designates this activity for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.00 MOC in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Available Credit
- 2.00 ABIM MOC Self Evaluation PointsSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 2.00 AMA PRA Category 1 Credit™
Price
The following is an interactive educational module designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of several sections: a pre-test, a study program, a post-test, and CME evaluation. All sections must be completed to receive CME credit.
Click START to begin.
If you are a Program Director and would like to grant access to your trainees, please reach out to education@hospitalmedicine.org for an academic access code.